SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-076654
Filing Date
2014-02-28
Accepted
2014-02-28 14:39:28
Documents
15
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d668864d10k.htm 10-K 1006008
2 EX-21.1 d668864dex211.htm EX-21.1 2107
3 EX-23.1 d668864dex231.htm EX-23.1 2308
4 EX-31.1 d668864dex311.htm EX-31.1 8180
5 EX-31.2 d668864dex312.htm EX-31.2 8177
6 EX-32.1 d668864dex321.htm EX-32.1 2589
7 EX-32.2 d668864dex322.htm EX-32.2 2556
14 GRAPHIC g668864g29a92.jpg GRAPHIC 79881
15 GRAPHIC g668864g82l85.jpg GRAPHIC 109758
  Complete submission text file 0001193125-14-076654.txt   7240895

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT clvs-20131231.xml EX-101.INS 889235
9 XBRL TAXONOMY EXTENSION SCHEMA clvs-20131231.xsd EX-101.SCH 68809
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clvs-20131231_cal.xml EX-101.CAL 86577
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clvs-20131231_def.xml EX-101.DEF 412618
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE clvs-20131231_lab.xml EX-101.LAB 530971
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clvs-20131231_pre.xml EX-101.PRE 482176
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35347 | Film No.: 14654170
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences